Search BRITE hierarchies

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
  N NERVOUS SYSTEM
    N04 ANTI-PARKINSON DRUGS
      N04B DOPAMINERGIC AGENTS
        N04BX Other dopaminergic agents
          N04BX02 Entacapone
            D00781  Entacapone (JP18/USP/INN) <JP/US>

USP drug classification [BR:br08302]
  Antiparkinson Agents
    Antiparkinson Agents, Other
      Entacapone
        D00781  Entacapone (JP18/USP/INN)

Therapeutic category of drugs in Japan [BR:br08301]
  1  Agents affecting nervous system and sensory organs
    11  Agents affecting central nervous system
      116  Antiparkinsonian agents
        1169  Others
          D00781  Entacapone (JP18/USP/INN)

Drug groups [BR:br08330]
  Neuropsychiatric agent
    DG01497  Catechol O-methyltransferase inhibitor
      D00781  Entacapone
    DG01967  Antiparkinson agent
      DG02909  COMT inhibitor
        D00781  Entacapone
  Metabolizing enzyme inhibitor
    DG01643  CYP2C9 inhibitor
      D00781  Entacapone

Drug classes [BR:br08332]
  Neuropsychiatric agent
    DG01967  Antiparkinson agent
      D00781  Entacapone

Target-based classification of drugs [BR:br08310]
  Enzymes
    Transferases (EC2)
      Methyltransferases [EC:2.1.1.-]
        COMT [HSA:1312] [KO:K00545]
          D00781  Entacapone (JP18/USP/INN) <JP/US>

Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
  Chemicals
    D00781  Entacapone
    D00781  Entacapone tablets

New drug approvals in the USA [br08319.html]
  D00781

New drug approvals in Europe [br08329.html]
  D00781

New drug approvals in Japan [br08318.html]
  D00781

New drug approvals in the USA, Europe and Japan [br08328.html]
  D00781

Drug metabolizing enzymes and transporters [br08309.html]
  D00781